• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一组耐辐射前列腺癌细胞的分析鉴定出关键微小RNA的失调。

Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs.

作者信息

McDermott Niamh, Meunier Armelle, Wong Simon, Buchete Vio, Marignol Laure

机构信息

Trinity Translational Medicine Institute, Translational Radiobiology and Molecular Oncology, Applied Radiation Therapy Trinity, Discipline of Radiation Therapy, Trinity College Dublin, Ireland.

Irish Centre for High-End Computing, National University of Ireland, Galway, Ireland.

出版信息

Clin Transl Radiat Oncol. 2017 Feb 17;2:63-68. doi: 10.1016/j.ctro.2017.01.005. eCollection 2017 Feb.

DOI:10.1016/j.ctro.2017.01.005
PMID:29658003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5893531/
Abstract

BACKGROUND

miRNAs are increasingly associated with the aggressive phenotype of prostate tumours. Their ability to control radiobiologically-relevant cellular processes strengthens their potential as novel markers of response to radiation therapy.

PURPOSE

To identify miRNAs associated with increased clonogenic survival following radiation exposure.

MATERIAL AND METHODS

The miRNA expression profiles of a panel of 22RV1 cells with varying levels of radiosensitivities (hypoxic H-22Rv1 cells, RR-22Rv1 cells derived from WT-22Rv1 cells through 2-Gy fractionated repeated exposure, the associated aged matched cells (AMC-22Rv1) and the WT-22Rv1 cell lines) were generated and cross-analysed to identify common miRNAs associated with a radioresistant phenotype.

RESULTS

Increased clonogenic survival following irradiation was associated with significant modifications in miRNA expression pattern. miR-221 (up) and miR-4284 (down) in RR-22Rv1 and MiR-31 and miR-200c in AMC-22Rv1 were the most uniquely significantly deregulated miRNAs when compared to WT-22Rv1 cells. miR-200c ranked as the most downregulated miRNAs in hypoxic, when compared to RR-22Rv1 cells. miR-200a was the only differentially expressed miRNA between RR-22Rv1 and AMC-22Rv1 cells. miR-210 yielded the highest fold change in expression in H-22Rv1, when compared to WT-22RV1 cells.

CONCLUSION

This study identifies candidate miRNAs for the development of novel prognostic biomarkers for radiotherapy prostate cancer patients.

摘要

背景

微小RNA(miRNA)与前列腺肿瘤的侵袭性表型越来越相关。它们控制放射生物学相关细胞过程的能力增强了其作为放射治疗反应新标志物的潜力。

目的

鉴定与辐射暴露后克隆形成存活率增加相关的miRNA。

材料与方法

生成并交叉分析了一组具有不同放射敏感性水平的22RV1细胞(缺氧的H-22Rv1细胞、通过2 Gy分次重复照射从WT-22Rv1细胞衍生而来的RR-22Rv1细胞、相关的年龄匹配细胞(AMC-22Rv1)和WT-22Rv1细胞系)的miRNA表达谱,以鉴定与放射抗性表型相关的常见miRNA。

结果

照射后克隆形成存活率增加与miRNA表达模式的显著改变有关。与WT-22Rv1细胞相比,RR-22Rv1中的miR-221(上调)和miR-4284(下调)以及AMC-22Rv1中的MiR-31和miR-200c是最独特且显著失调的miRNA。与RR-22Rv1细胞相比,miR-200c在缺氧条件下是下调最明显的miRNA。miR-200a是RR-22Rv1和AMC-22Rv1细胞之间唯一差异表达的miRNA。与WT-22RV1细胞相比,miR-210在H-22Rv1中的表达变化倍数最高。

结论

本研究确定了用于开发前列腺癌放疗患者新型预后生物标志物的候选miRNA。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f24/5893531/2638b7c4ebc1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f24/5893531/6b0f0e496d31/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f24/5893531/bc9e284db564/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f24/5893531/e7f23fbbabc5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f24/5893531/2638b7c4ebc1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f24/5893531/6b0f0e496d31/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f24/5893531/bc9e284db564/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f24/5893531/e7f23fbbabc5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f24/5893531/2638b7c4ebc1/gr4.jpg

相似文献

1
Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs.一组耐辐射前列腺癌细胞的分析鉴定出关键微小RNA的失调。
Clin Transl Radiat Oncol. 2017 Feb 17;2:63-68. doi: 10.1016/j.ctro.2017.01.005. eCollection 2017 Feb.
2
Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells.分次辐射暴露会增强前列腺癌细胞的辐射抗性。
Sci Rep. 2016 Oct 5;6:34796. doi: 10.1038/srep34796.
3
Regulation of miR-200c and miR-141 by Methylation in Prostate Cancer.前列腺癌中miR-200c和miR-141的甲基化调控
Prostate. 2016 Sep;76(13):1146-59. doi: 10.1002/pros.23201. Epub 2016 May 16.
4
Integrated analysis of miRNA landscape and cellular networking pathways in stage-specific prostate cancer.特定分期前列腺癌中 miRNA 图谱与细胞网络通路的综合分析
PLoS One. 2019 Nov 22;14(11):e0224071. doi: 10.1371/journal.pone.0224071. eCollection 2019.
5
Systematic large-scale meta-analysis identifies miRNA-429/200a/b and miRNA-141/200c clusters as biomarkers for necrotizing enterocolitis in newborn.系统大规模荟萃分析确定 microRNA-429/200a/b 和 microRNA-141/200c 簇作为新生儿坏死性小肠结肠炎的生物标志物。
Biosci Rep. 2019 Sep 24;39(9). doi: 10.1042/BSR20191503. Print 2019 Sep 30.
6
MicroRNA response to hypoxic stress in soft tissue sarcoma cells: microRNA mediated regulation of HIF3α.软组织肉瘤细胞中微小RNA对缺氧应激的反应:微小RNA介导的低氧诱导因子3α调控
BMC Cancer. 2014 Jun 13;14:429. doi: 10.1186/1471-2407-14-429.
7
Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.浆液性和透明细胞卵巢癌的全球 miRNA 表达分析确定了差异表达的 miRNA,包括 miR-200c-3p 作为一个预后标志物。
BMC Cancer. 2014 Feb 11;14:80. doi: 10.1186/1471-2407-14-80.
8
MicroRNAs and zinc metabolism-related gene expression in prostate cancer cell lines treated with zinc(II) ions.锌离子处理前列腺癌细胞系中 microRNAs 和锌代谢相关基因表达。
Int J Oncol. 2012 Dec;41(6):2237-44. doi: 10.3892/ijo.2012.1655. Epub 2012 Oct 9.
9
A specific miRNA signature promotes radioresistance of human cervical cancer cells.特定的 miRNA 特征可促进人宫颈癌细胞的放射抵抗性。
Cancer Cell Int. 2013 Nov 27;13(1):118. doi: 10.1186/1475-2867-13-118.
10
Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.综合 microRNA 表达谱分析鉴定滤泡型甲状腺癌的新型标志物。
Thyroid. 2013 Nov;23(11):1383-9. doi: 10.1089/thy.2012.0632. Epub 2013 Sep 19.

引用本文的文献

1
The Evolving Landscape of Novel and Old Biomarkers in Localized High-Risk Prostate Cancer: State of the Art, Clinical Utility, and Limitations Toward Precision Oncology.局限性高危前列腺癌中新旧生物标志物的演变格局:精准肿瘤学的现状、临床应用及局限性
J Pers Med. 2025 Aug 11;15(8):367. doi: 10.3390/jpm15080367.
2
Loss of miR-200c-3p promotes resistance to radiation therapy via the DNA repair pathway in prostate cancer.miR-200c-3p 的缺失通过 DNA 修复途径促进前列腺癌对放射治疗的抵抗。
Cell Death Dis. 2024 Oct 16;15(10):751. doi: 10.1038/s41419-024-07133-3.
3
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy.

本文引用的文献

1
Emergence of miR-34a in radiation therapy.miR-34a在放射治疗中的出现。
Crit Rev Oncol Hematol. 2017 Jan;109:69-78. doi: 10.1016/j.critrevonc.2016.11.017. Epub 2016 Dec 1.
2
Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.前列腺癌和良性前列腺增生中血清微小RNA的不同水平:潜在诊断和预后作用的评估
Onco Targets Ther. 2016 Dec 13;9:7545-7553. doi: 10.2147/OTT.S119027. eCollection 2016.
3
Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
SGLT2 抑制剂卡格列净抑制前列腺癌细胞生长并增强其对放射治疗的敏感性。
Commun Biol. 2023 Sep 8;6(1):919. doi: 10.1038/s42003-023-05289-w.
4
Generation of Radioresistant Prostate Cancer Cells.生成耐辐射前列腺癌细胞。
Methods Mol Biol. 2023;2645:129-138. doi: 10.1007/978-1-0716-3056-3_5.
5
Improving the prediction for the response to radiotherapy of clinical tumor samples by using combinatorial model of MicroRNA expression.利用微小RNA表达组合模型改善临床肿瘤样本放疗反应预测
Front Genet. 2022 Nov 22;13:1069112. doi: 10.3389/fgene.2022.1069112. eCollection 2022.
6
Biological Mechanisms to Reduce Radioresistance and Increase the Efficacy of Radiotherapy: State of the Art.减少放疗抵抗性和提高放疗疗效的生物学机制:现状。
Int J Mol Sci. 2022 Sep 6;23(18):10211. doi: 10.3390/ijms231810211.
7
Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy.循环微RNA作为接受放疗的前列腺癌患者的潜在生物标志物
Cancer Manag Res. 2021 Nov 2;13:8257-8271. doi: 10.2147/CMAR.S325246. eCollection 2021.
8
The Influence of miRNAs on Radiotherapy Treatment in Prostate Cancer - A Systematic Review.微小RNA对前列腺癌放射治疗的影响——一项系统综述
Front Oncol. 2021 Aug 3;11:704664. doi: 10.3389/fonc.2021.704664. eCollection 2021.
9
miR-4284 Promotes Cell Proliferation, Migration, and Invasion in Non-Small Cell Lung Cancer Cells and is Associated with Postoperative Prognosis.miR-4284促进非小细胞肺癌细胞的增殖、迁移和侵袭,并与术后预后相关。
Cancer Manag Res. 2021 Jul 28;13:5865-5872. doi: 10.2147/CMAR.S305379. eCollection 2021.
10
Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients.前列腺癌患者诊断、预后及治疗反应的血液源性生物标志物
J Pers Med. 2021 Apr 13;11(4):296. doi: 10.3390/jpm11040296.
微小RNA作为前列腺癌诊断和预后生物标志物的最新情况。
Urol Oncol. 2017 Mar;35(3):92-101. doi: 10.1016/j.urolonc.2016.10.019. Epub 2016 Nov 24.
4
Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells.分次辐射暴露会增强前列腺癌细胞的辐射抗性。
Sci Rep. 2016 Oct 5;6:34796. doi: 10.1038/srep34796.
5
Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening.通过互补功能微小RNA文库筛选鉴定miR-30b-3p和miR-30d-5p为前列腺癌中雄激素受体信号通路的直接调节因子。
Oncotarget. 2016 Nov 8;7(45):72593-72607. doi: 10.18632/oncotarget.12241.
6
Hypoxia-Responsive Mir-301a and Mir-301b Promote Radioresistance of Prostate Cancer Cells via Downregulating NDRG2.缺氧反应性微小RNA-301a和微小RNA-301b通过下调NDRG2促进前列腺癌细胞的放射抗性。
Med Sci Monit. 2016 Jun 21;22:2126-32. doi: 10.12659/msm.896832.
7
Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer.癌基因miR-130通过靶向胃癌中的TGFβR2促进细胞增殖和迁移。
Oncotarget. 2016 Jul 12;7(28):44522-44533. doi: 10.18632/oncotarget.9936.
8
MicroRNAs and Their Impact on Radiotherapy for Cancer.微小RNA及其对癌症放射治疗的影响。
Radiat Res. 2016 Jun;185(6):668-77. doi: 10.1667/RR14370.1. Epub 2016 May 25.
9
miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.癌细胞和肿瘤微环境中的微小RNA失调
Cancer Discov. 2016 Mar;6(3):235-46. doi: 10.1158/2159-8290.CD-15-0893. Epub 2016 Feb 10.
10
A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.一项关于与良性前列腺增生相比,前列腺癌中失调的错配修复基因分子信号的研究。
PLoS One. 2015 May 4;10(5):e0125560. doi: 10.1371/journal.pone.0125560. eCollection 2015.